HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beneficial effect of a synthetic prostacyclin agonist, ONO-1301, in rat autoimmune myocarditis model.

Abstract
Injury to the heart can result in cardiomyocyte hypertrophy, fibrosis, and cell death. Myocarditis sometimes progresses to dilated cardiomyopathy. We previously reported that ONO-1301, a synthetic prostacyclin agonist with thromboxane-synthase inhibitory activity, promotes production of hepatocyte growth factor (HGF) from various cell types and ameliorates ischemia-induced left ventricle dysfunction in the mouse, rat and pig. Here, we investigated the therapeutic efficacy of ONO-1301 in a rat model of myosin-induced experimental autoimmune myocarditis, in which the heart transits from an acute inflammatory phase to a chronic dilated cardiomyopathy phase. Four weeks after myosin injection to Lewis rats, ONO-1301 (6 mg/kg/day) was orally administered for 4 weeks (ONO-1301 group). Hemodynamic parameters and plasma brain natriuretic peptide (BNP) level were significantly improved by ONO-1301. Histological analysis revealed that capillary density in the myocardium was significantly increased by ONO-1301. ONO-1301 increased circulating endothelial progenitor cells (EPC) as determined by FACS analysis. These beneficial effects of ONO-1301 were partially abrogated by a neutralizing anti-HGF antibody (8 mg/kg/dose). These findings indicate beneficial effects of ONO-1301 in a rat experimental autoimmune myocarditis model.
AuthorsYoichiro Hirata, Hirotsugu Kurobe, Etsuko Uematsu, Shusuke Yagi, Takeshi Soeki, Hirotsugu Yamada, Daiju Fukuda, Michio Shimabukuro, Mizuho Nakayama, Kunio Matsumoto, Yoshiki Sakai, Tetsuya Kitagawa, Masataka Sata
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 699 Issue 1-3 Pg. 81-7 (Jan 15 2013) ISSN: 1879-0712 [Electronic] Netherlands
PMID23219794 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • Pyridines
  • Natriuretic Peptide, Brain
  • ONO 1301
  • Myosins
Topics
  • Administration, Oral
  • Animals
  • Autoimmune Diseases (drug therapy, physiopathology)
  • Cardiomyopathy, Dilated (drug therapy, physiopathology)
  • Disease Models, Animal
  • Endothelial Cells (metabolism)
  • Hemodynamics (drug effects)
  • Male
  • Myocarditis (drug therapy, immunology, physiopathology)
  • Myosins (immunology)
  • Natriuretic Peptide, Brain (blood)
  • Pyridines (pharmacology)
  • Rats
  • Rats, Inbred Lew
  • Stem Cells (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: